91奇迹

 找回密码
 中文注册
查看: 858|回复: 5

现在哪里有ZD6474实验组吗

[复制链接]
发表于 2009-11-8 14:17:56 | 显示全部楼层 |阅读模式 来自: 中国北京
求助,各位知道国内哪里有ZD6474的实验组吗, 入组需要什么条件, 哪位能给提供些信息,非常感谢
有爱,就有奇迹!
 楼主| 发表于 2009-11-9 15:48:49 | 显示全部楼层 来自: 中国北京
没人能够回答的问题
有爱,就有奇迹!
发表于 2009-11-9 17:36:21 | 显示全部楼层 来自: 中国江苏南京

国内好象已经都结束了.美国好象已经可以买到了

国内好象已经都结束了.美国好象已经可以买到了
有爱,就有奇迹!
发表于 2009-11-9 22:45:39 | 显示全部楼层 来自: 中国上海
原帖由 救我慈父 于 2009-11-8 14:17 发表
求助,各位知道国内哪里有ZD6474的实验组吗, 入组需要什么条件, 哪位能给提供些信息,非常感谢

去年年底的时候,上海肺科医院还有6474,现在我不太知道了。你可以电话问问看。
有爱,就有奇迹!
发表于 2009-11-9 22:55:12 | 显示全部楼层 来自: 美国
AstraZeneca cancels lung cancer drug applications
Associated Press, 10.28.09, 06:54 AM EDT  

LONDON -- AstraZeneca PLC said Wednesday it has withdrawn applications for regulatory approval for its lung cancer drug Zactima following disappointing trial results.

The pharmaceutical company had been seeking regulatory clearance in the United States and European Union to use Zactima - generic name vandetanib - in combination with chemotherapy for treating advanced non-small cell lung cancer.

"The decision to withdraw these submissions was based on an updated analysis that demonstrated no overall survival advantage when vandetanib was added to chemotherapy," the company said. Regulators had also hinted that the results were insufficient for approval, the company added.

AstraZeneca ( AZN - news - people ) said it will complete a trial program which is expected to give more results on the efficacy of the drug in difference clinical settings.
有爱,就有奇迹!
发表于 2009-11-9 23:03:09 | 显示全部楼层 来自: 中国北京
阿斯利康撤回了在美国通过Zactima配合化疗方案的申请,因为三期实验看不出有什么显著疗效。目前单药Zactima,尤其针对易瑞沙和特罗凯耐药后患者的实验,还在继续。大概在这几个月应该会有一个比较大的实验报告结果,大家可以关注一下新闻。
有爱,就有奇迹!
您需要登录后才可以回帖 登录 | 中文注册

本版积分规则

QQ|关于我们|隐私服务条款|小黑屋|手机版|91奇迹 ( 京ICP备2020048145号-6 )

GMT+8, 2025-1-11 21:58 , Processed in 0.051309 second(s), 19 queries .

Powered by Discuz! X3.4

Copyright © 2001-2023, Tencent Cloud.

快速回复 返回顶部 返回列表